During the past decade, Urological Sciences Research Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Urological Sciences Research Foundation" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Solvay Pharmaceuticals" with 1 trials as a collaborator and "Watson Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Urological Sciences Research Foundation" are "Benign Prostatic Hyperplasia" (1 trials), "Men With Low Testosterone Levels" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Urological Sciences Research Foundation" in a lesser frequency.

Most popular intervention types in "Urological Sciences Research Foundation" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Botox" (1 trials), "Lonidamine" (1 trials), "Placebo" (1 trials) and "Testosterone Enanthate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Urological Sciences Research Foundation" are 3 trials for "Male" genders.

Currently, there are NaN active trials in "Urological Sciences Research Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Urological Sciences Research Foundation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Urological Sciences Research Foundation, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".